Advanced in Cholangiocarcinoma (Bile Duct Cancer)

Xiaobo L. Yang

State Key Laboratory Of Complex Severe And Rare Diseases, Peking Union Medical College Hospital, Chinese Academy Of Medical Sciences And Peking Union Medical College
Beijing, CN 
Advanced in Cholangiocarcinoma (Bile Duct Cancer)
State Key Laboratory Of Complex Severe And Rare Diseases, Peking Union Medical College Hospital, Chinese Academy Of Medical Sciences And Peking Union Medical College
Beijing, CN 
OverviewLocationsClinical Research

Overview

Xiaobo Yang practices in Beijing, China. Yang is rated as an Advanced expert by MediFind in the treatment of Cholangiocarcinoma (Bile Duct Cancer). Their top areas of expertise are Liver Cancer, Gallbladder Adenocarcinoma, Cholangiocarcinoma (Bile Duct Cancer), Hepato-Pancreato-Biliary Surgery, and Hepatectomy.

Their clinical research consists of co-authoring 164 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, they have co-authored 23 articles in the study of Cholangiocarcinoma (Bile Duct Cancer).

Locations

State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College
Beijing, China
Other Locations
Tianjin, 300050, China
State Key Laboratory Of Complex Severe And Rare Diseases, Peking Union Medical College Hospital, #1 Shuaifuyuan, Wangfujing, 100730, China
Nantong, 226019, China
Shangtang Road 158, 310014, Hangzhou, China
Shucheng, 117910, China
Suzhou, 215006, China
Xuzhou, China
Haidian, China
Baoding, China

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

164 Total Publications

A sensitive quantitative detection technology for tetracycline and erythromycin based on allosteric transcription factors (aTFs) using SPR.
A sensitive quantitative detection technology for tetracycline and erythromycin based on allosteric transcription factors (aTFs) using SPR.
Journal: Analytical methods : advancing methods and applications
Published: October 02, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Yang's expertise for a condition
ConditionClose
      View All 17 Experienced Conditions
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile